The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...

Valeant, Galderma revise dermal filler supply deal

Valeant Pharmaceuticals International Inc. said Thursday it reached a new supply agreement with Galderma SA, which makes dermal fillers including Restylane and Perlane.Galderma makes the products for...

Valeant Pharmaceuticals and Galderma enter an aesthetics arrangement

Valeant Pharmaceuticals International has reached agreement on terms of a revised North American aesthetics arrangement with Galderma. Under the terms of the revised agreement, Galderma will continue...

Galderma: Company profile

Return to top 50 pharma list Summary Website: Galderma Headquarters: Lausanne, Switzerland Ticker Symbol: Owned Privatley SEC Link: Galderma SEC filings Subsidiaries: CollaGenex Medion Diagnostics...

Galderma set to launch Nuvo's Pliaglis in EU

Dermatology company Galderma has received its first three EU marketing licences for its topical pain drug Pliaglis (tetracaine and lidocaine), with plans to launch in the first half of 2013. Pliaglis...

Galderma to acquire Spirig

Pharmaceutical company Galderma is poised to acquire Spirig Pharma, a move that will boost its line of products for treating various dermatologic conditions.

Galderma funds NVC-422 development

NovaBay Pharmaceuticals has received $2.6m from partner Galderma for clinical advancement of NovaBay's "non-antibiotic, anti-infective" Aganocide compound NVC-422 as a topical formulation to replace t...

Galderma, Ipsen extend Dysport collaboration

Ipsen and Galderma have extended their collaboration to promote and distribute Dysport, Ipsen's botulinum toxin type A in aesthetic indications.

Nuvo Research gibt europäische Markteinführung von Pliaglis durch Galderma bekannt

Nuvo Research Inc. (TSX:NRI), ein Spezial-Pharmaunternehmen, das sich mit dem Aufbau eines Produktportfolios für die topische Behandlung von Schmerzen beschäftigt, und Galderma Pharma, S.A. (Galde.....

Effect of a new moisturizing lotion on immediate and cumulative skin hydration: Two randomized, intra-individual, vehicle- and comparator-controlled studies.

Abstract Moisturizers increase skin hydration and can serve as adjunctive care in dermatologic conditions such as xerosis, psoriasis vulgaris, atopic dermatitis and ichthyosis, in which dry skin is im...

The France-PDT study: A national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.

Background. The efficacy and safety of MAL-PDT have been shown in actinic keratoses (AK), basal cell carcinoma (BCC), and Bowen's disease (BD). Objectives. To appraise the current use of MAL-PDT in Fr...

Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris - A multicenter, randomised, double-blind controlled study.

Background:  Oral antibiotics in association with a topical retinoid with or without benzoyl peroxide (BPO) are the recommended first-line option in the treatment of moderate to severe acne vulgaris...